












Jasper Edgar Neggers
Founder at Promakhos Therapeutics
CSO and co-founder of Promakhos. In high school, Jasper built a web-shop. He obtained a BSc, MSc and PhD in Biomedical Sciences from KU Leuven. He pioneered the use of XPO1 inhibitors for treating cancer and invented a CRISPR-directed evolution technology for drug target deconvolution. Jasper then joined the Dana-Farber Cancer Institute & Broad Institute of MIT and Harvard to identify and validate new drug targets for gastrointestinal cancers. Now, he develops drugs for chronic inflammation.
Follow Jasper
Previously at

Harvard University

Broad Institute of MIT and Harvard

Dana-Farber Cancer Institute
Miniprise VOF
Alumnus of

KU Leuven